CR-9114

N/A

Report date: 2022/04/02 11:35:23

Base Information

Drug NameCR-9114
Drug Alias NameCR-9114
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeyden Laboratories BV
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceuticals IncLeyden Laboratories BV
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A